# Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer

> **NCT01126645** · PHASE2 · COMPLETED · sponsor: **University of Magdeburg** · enrollment: 529 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** RFA
- **PROCEDURE:** Radioembolization (SIRT)

## Key facts

- **NCT ID:** NCT01126645
- **Lead sponsor:** University of Magdeburg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2018-01-25
- **Final completion:** 2018-12-31
- **Target enrollment:** 529 (ACTUAL)
- **Last updated:** 2019-05-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01126645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01126645, "Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01126645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*